OR WAIT null SECS
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
AAI Acquires CAC
ePT--the Electronic Newsletter of Pharmaceutical Technology
Wilmington, NC (Oct. 26)?AAIPharma Inc. has completed its acquisition of contract research organization Cvitkovic & Associes Consultants S.A.
Wilmington, NC (Oct. 26)-AAIPharma Inc. (www.aaipharma.com) completed its acquisition of contract research organization Cvitkovic & Associes Consultants S.A. (CAC, Le Kremlin Bicetre, France). CAC, which specializes in oncology drug development and medical consulting, will form the foundation of AAIOncology, a global business unit dedicated to developing cancer-fighting drugs.
According to Vito Mangiardi, AAI’s president of North American operations, “The experience and expertise brought by our new colleagues in the area of … oncology will significantly strengthen our company’s ability to execute large and global late-stage clinical development programs.”
The acquisition was made possible through a rights offering to existing shareholders and option holders that raised $30 million. The offering was backstopped by a group of principal shareholders led by JPMorgan.
